Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 995 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

SRI secures $14.3m service contracts from NCI

The research company will receive $11.7m for toxicology studies and an additional $2.6 m for pharmacology and pharmacokinetics studies which will be conducted through NCI’s Developmental Therapeutics Program.

DreamBrands unveils testosterone boosting supplement

The product, Mdrive comprises a blend of bio-active extracts from plants, roots, herbs and mushrooms which are scientifically formulated to support the adrenal gland besides increasing testosterone levels,.

Teriflunomide shows positive data in MS treatment

Teriflunomide is an immunomodulatory, disease-modifying oral drug with anti-inflammatory properties. The two-year TEMSO (TEriflunomide Multiple Sclerosis Oral) trial involved 1,088 patients with relapsing forms of MS and showed

BioCancell to begin pancreatic cancer clinical trial

The trial will evaluate the efficacy of BioCancell’s BC-819 in sequence with Gemcitabine, in treating locally-advanced, unresectable pancreatic cancer. pbpb About 100 participants are expected to be enrolled

Sinclair adopts CRM software solution

The software will be implemented by the pharma company for its commercial teams in the five largest European countries. The tool, developed to cater to the needs of

Accudial buys Stephen Key Design

Stephen Key will lay emphasis on pharmaceutical applications for prescription, over-the-counter, nutritional supplements, injectable vials and vitamins. Stephen Key Design is specialized in Spinformation rotating label technology with

CCO adds new database to inPractice

ClinicalTrials.gov provides updated information on federally and privately supported clinical trials for a wide range of diseases and conditions. Currently, the database comprises 113,224 sponsored trials conducted in